0.7720
-0.0655
(-7.82%)
At close: January 10 at 9:39:33 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 2 | 4 | 4 |
Avg. Estimate | 300k | -- | 3.62M | -- |
Low Estimate | -- | -- | 3.29M | -- |
High Estimate | 1.2M | -- | 4.6M | -- |
Year Ago Sales | 1.42M | 1.01M | 6.04M | 3.62M |
Sales Growth (year/est) | -78.86% | -100.00% | -40.02% | -100.00% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
2H51.F | -- | -- | -- | -- |
S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
Maintains | Chardan Capital: Buy to Buy | 11/18/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
Maintains | Chardan Capital: Buy to Buy | 11/9/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 10/23/2024 |
Initiated | Maxim Group: Buy | 10/15/2024 |
Related Tickers
5CV.HA CureVac NV
4.2460
+8.82%
NVV1.SG Novavax Inc
8.99
-2.96%
AYJ.F Valneva SE
2.2840
+6.73%
NVV1.F Novavax, Inc.
8.89
-6.92%
PHM.MC Pharma Mar, S.A.
77.20
-1.72%
PHIO Phio Pharmaceuticals Corp.
1.6900
0.00%
LSTA Lisata Therapeutics, Inc.
3.7300
-1.84%
RAPT RAPT Therapeutics, Inc.
1.3200
-8.97%
ATNM Actinium Pharmaceuticals, Inc.
1.2800
-2.29%
IBIO iBio, Inc.
2.5500
-6.25%